Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 10 (6), 444-51

Molecular Function of TCF7L2: Consequences of TCF7L2 Splicing for Molecular Function and Risk for Type 2 Diabetes

Affiliations
Review

Molecular Function of TCF7L2: Consequences of TCF7L2 Splicing for Molecular Function and Risk for Type 2 Diabetes

Ola Hansson et al. Curr Diab Rep.

Abstract

TCF7L2 harbors the variant with the strongest effect on type 2 diabetes (T2D) identified to date, yet the molecular mechanism as to how variation in the gene increases the risk for developing T2D remains elusive. The phenotypic changes associated with the risk genotype suggest that T2D arises as a consequence of reduced islet mass and/or impaired function, and it has become clear that TCF7L2 plays an important role for several vital functions in the pancreatic islet. TCF7L2 comprises 17 exons, five of which are alternative (ie, exons 4 and 13-16). In pancreatic islets four splice variants of TCF7L2 are predominantly expressed. The regulation of these variants and the functional consequences at the protein level are still poorly understood. A clear picture of the molecular mechanism will be necessary to understand how an intronic variation in TCF7L2 can influence islet function.

Similar articles

See all similar articles

Cited by 24 articles

See all "Cited by" articles

References

    1. J Mol Med (Berl). 2006 Dec;84(12 ):1005-14 - PubMed
    1. Diabetologia. 2008 Jan;51(1):147-54 - PubMed
    1. Development. 2005 Nov;132(21):4663-74 - PubMed
    1. Mol Cell Biol. 2008 Apr;28(8):2732-44 - PubMed
    1. Science. 1998 Sep 4;281(5382):1509-12 - PubMed

MeSH terms

Substances

LinkOut - more resources

Feedback